Stephen A. Firkins

Impacts of glucagon‐like peptide‐1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction‐associated steatotic liver disease cirrhosis and type 2 diabetes

Mohamed I. Elsaid, Na Li, Stephen A. Firkins et al. · Alimentary Pharmacology & Therapeutics · 2024 · 67 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Clinical Outcomes and Safety of Upper Endoscopy While on Glucagon-Like Peptide-1 Receptor Agonists

Stephen A. Firkins, J. C. Yates, Neehal Shukla et al. · Clinical Gastroenterology and Hepatology · 2024 · 31 citations · Full text

Medicine, Endocrinology, Internal Medicine +16

Utilization of Anti-obesity Medications After Bariatric Surgery: Analysis of a Large National Database

Stephen A. Firkins, Vibhu Chittajallu, Bailey Flora et al. · Obesity Surgery · 2024 · 18 citations

Pharmacy, Pharmacotherapy, Surgery +13

Identification of a Risk Profile for New-Onset Diabetes After Acute Pancreatitis

Stephen A. Firkins, Phil A. Hart, Georgios I. Papachristou et al. · Pancreas · 2021 · 15 citations · Full text

Medicine, Health Sciences, Clinical Epidemiology +15

Association of Bariatric Surgery with Risk of Incident Obesity-Associated Malignancies: a Multi-center Population-Based Study

Vibhu Chittajallu, Emad Mansoor, Yazan Abu Omar et al. · Obesity Surgery · 2023 · 13 citations

Medicine, Oncology, Surgery +13